Claudia Ielo

5PUBLICATIONS
6CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 08, 2025
Clinical Relevance and Prognostic Value of the Triple A (AAA) Score in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX).

Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna

|Dec 08, 2024
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML).

Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna

|Feb 09, 2024
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation.

Alessandro Laganà, Mauro Passucci, Sara Pepe

|Dec 14, 2023
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.

Alessandro Costa, Ida Carmosino, Emilia Scalzulli

Pageof 1